{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:30:01Z","timestamp":1793413801005,"version":"4.5.0"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Heart failure with reduced ejection fraction (HFrEF) accounts for over half of heart failure cases and its management is directed by international clinical practice guidelines. To evaluate current recommendations, we conducted a systematic review of guidelines on the diagnosis and management of HFrEF in adults. MEDLINE and EMBASE were searched on 10 November 2024 for publications within the past decade, and websites of relevant medical societies were reviewed. Twelve guidelines were identified, of which seven met predefined AGREE II criteria for methodological \u2018rigour of development\u2019 and were included in the final analysis. Across the selected guidelines, there was broad consensus on the prevention of heart failure, the definition of HFrEF, and the initial diagnostic approach. Recommended investigations included coronary CT angiography, cardiac magnetic resonance imaging, and invasive coronary angiography in selected patients. There was also agreement on the principles of pharmacological management, with consistent endorsement of foundational therapies such as renin\u2013angiotensin\u2013aldosterone system (RAAS) inhibitors, beta-blockers, mineralocorticoid receptor antagonists, and sodium\u2013glucose cotransporter 2 inhibitors. However, key differences emerged regarding thresholds for serum natriuretic peptides, sequencing of RAAS inhibitors, and device-based therapies including implantable defibrillators in non-ischaemic HFrEF, cardiac resynchronization therapy, and indications for coronary revascularization. Variability was also noted in staging, particularly the identification and management of stage A (at-risk) and stage B (pre-heart failure). Only a minority of guidelines addressed common comorbidities such as iron deficiency, atrial fibrillation, obesity, sleep-disordered breathing, and frailty. Our findings underscore the need for greater harmonization to standardize and optimize HFrEF care worldwide.<\/jats:p>","DOI":"10.1093\/ehjqcco\/qcag029","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:38:13Z","timestamp":1772541493000},"page":"679-703","source":"Crossref","is-referenced-by-count":4,"title":["Heart failure with reduced ejection fraction: a systematic review of clinical practice guidelines and recommendations"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6792-3895","authenticated-orcid":false,"given":"Shayan","family":"Datta","sequence":"first","affiliation":[{"name":"Department of Medicine, University College London Hospitals NHS Foundation Trust , London NW1 2PG ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunrit","family":"Majumder","sequence":"additional","affiliation":[{"name":"Department of Medicine, South Tees Hospitals NHS Foundation Trust , Middlesbrough TS4 3BW ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav S","family":"Gulsin","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester and the National Institute for Health Research Leicester Biomedical Research Centre, Glenfield Hospital , Leicester LE3 9QP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitava","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, St Bartholomew\u2019s Hospital, Barts Health NHS Trust , West Smithfield, London EC1A 7BE ,","place":["UK"]},{"name":"University College London Institute of Health Informatics, University College London , 222 Euston Road, London NW1 2DA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P","family":"Primus","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, St Bartholomew\u2019s Hospital, Barts Health NHS Trust , West Smithfield, London EC1A 7BE ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma F","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Creighton University School of Medicine , Omaha, NE 68124 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9692-6616","authenticated-orcid":false,"given":"Fabrizio","family":"Ricci","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London , Charterhouse Square, London EC1M 6BQ ,","place":["UK"]},{"name":"Institute for Advanced Biomedical Technologies, \u2018G. D\u2019Annunzio\u2019 University of Chieti-Pescara , Via Luigi Polacchi 11, Chieti 66100 ,","place":["Italy"]},{"name":"Department of Neuroscience, Imaging and Clinical Sciences, \u2018G. d\u2019Annunzio University of Chieti-Pescara , Via dei Vestini 33, Chieti 66100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5095-1611","authenticated-orcid":false,"given":"Nay","family":"Aung","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, St Bartholomew\u2019s Hospital, Barts Health NHS Trust , West Smithfield, London EC1A 7BE ,","place":["UK"]},{"name":"William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London , Charterhouse Square, London EC1M 6BQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9037-0907","authenticated-orcid":false,"given":"Gautam","family":"Sen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, King\u2019s College Hospital NHS Foundation Trust , Golden Jubilee, Denmark Hill, London SE5 9RS ,","place":["UK"]},{"name":"British Heart Foundation Centre of Research Excellence, School of Cardiovascular and Metabolic Medicine and Sciences, King\u2019s College London , London SE5 9RS ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5512-7429","authenticated-orcid":false,"given":"Angela","family":"Gallagher","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, St Bartholomew\u2019s Hospital, Barts Health NHS Trust , West Smithfield, London EC1A 7BE ,","place":["UK"]},{"name":"Department of Cardiology, Newham University Hospital, Barts Health NHS Trust , Glen Road, London E13 8SL ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Anwar A","family":"Chahal","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, St Bartholomew\u2019s Hospital, Barts Health NHS Trust , West Smithfield, London EC1A 7BE ,","place":["UK"]},{"name":"William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London , Charterhouse Square, London EC1M 6BQ ,","place":["UK"]},{"name":"Center for Inherited Cardiovascular Diseases, WellSpan Health , 157 N Reading Rd. Ephrata, PA 17522 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-4454","authenticated-orcid":false,"given":"Mohammed Y","family":"Khanji","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, St Bartholomew\u2019s Hospital, Barts Health NHS Trust , West Smithfield, London EC1A 7BE ,","place":["UK"]},{"name":"William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London , Charterhouse Square, London EC1M 6BQ ,","place":["UK"]},{"name":"Department of Cardiology, Newham University Hospital, Barts Health NHS Trust , Glen Road, London E13 8SL ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"2026081102570719700_qcag029-B1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.cardfail.2025.07.007","article-title":"HF STATS 2025: heart failure epidemiology and outcomes statistics an updated 2025 report from the heart failure society of America","volume":"31","author":"WRITING COMMITTEE MEMBERS","year":"2025","journal-title":"J Card Fail"},{"key":"2026081102570719700_qcag029-B2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1001\/jamacardio.2023.0241","article-title":"Quality of care and outcomes among patients hospitalized for heart failure in rural vs urban US hospitals: the Get With The Guidelines\u2013Heart Failure registry","volume":"8","author":"Pierce","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2026081102570719700_qcag029-B3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter\u2013defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B4","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B5","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/ehjqcco\/qcae053","article-title":"Heart failure with preserved ejection fraction management: a systematic review of clinical practice guidelines and recommendations","volume":"10","author":"Mahmood","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026081102570719700_qcag029-B7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/ehjqcco\/qcae109","article-title":"Diagnosis and management of dilated cardiomyopathy: a systematic review of clinical practice guidelines and recommendations","volume":"11","author":"Sorella","year":"2025","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026081102570719700_qcag029-B8","volume-title":"Clinical Practice Guidelines: Management of Heart Failure 2023","author":"National Heart Association of Malaysia","year":"2023","edition":"5th ed"},{"key":"2026081102570719700_qcag029-B9","author":"National Institute for Health and Care Excellence"},{"key":"2026081102570719700_qcag029-B10","author":"National Institute for Health and Care Excellence"},{"key":"2026081102570719700_qcag029-B11","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"2026081102570719700_qcag029-B12","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026081102570719700_qcag029-B13","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026081102570719700_qcag029-B14","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure\u2014digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"2026081102570719700_qcag029-B15","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.cardfail.2021.04.023","article-title":"JCS\/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure","volume":"27","author":"Tsutsui","year":"2021","journal-title":"J Card Fail"},{"key":"2026081102570719700_qcag029-B16","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cjca.2017.08.022","article-title":"2017 comprehensive update of the Canadian cardiovascular society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"2026081102570719700_qcag029-B17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cjca.2021.01.017","article-title":"CCS\/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction","volume":"37","author":"McDonald","year":"2021","journal-title":"Can J Cardiol"},{"key":"2026081102570719700_qcag029-B18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.hlc.2018.06.1042","article-title":"National heart foundation of Australia and cardiac society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018","volume":"27","author":"NHFA CSANZ Heart Failure Guidelines Working Group","year":"2018","journal-title":"Heart Lung Circ"},{"key":"2026081102570719700_qcag029-B19","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2026081102570719700_qcag029-B21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.hfc.2020.12.001","article-title":"Asymptomatic left ventricular dysfunction: is there a role for screening in general population?","volume":"17","author":"Carrubba","year":"2021","journal-title":"Heart Fail Clin"},{"key":"2026081102570719700_qcag029-B22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2217\/fca-2021-0108","article-title":"Diagnostic accuracy of coronary computed tomography angiography in ischemic workup of heart failure: a meta-analysis","volume":"18","author":"Tiwari","year":"2022","journal-title":"Future Cardiol"},{"key":"2026081102570719700_qcag029-B23","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/ehjci\/jeaa109","article-title":"Computed tomography coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE-HF 1C)","volume":"22","author":"Chow","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026081102570719700_qcag029-B24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/ehjci\/jeab287","article-title":"Non-invasive imaging as the cornerstone of cardiovascular precision medicine","volume":"23","author":"Achenbach","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026081102570719700_qcag029-B25","doi-asserted-by":"publisher","first-page":"757596","DOI":"10.3389\/fcvm.2021.757596","article-title":"Prevalence and prognosis of HFimpEF developed from patients with heart failure with reduced ejection fraction: systematic review and meta-analysis","volume":"8","author":"He","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026081102570719700_qcag029-B26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","volume":"393","author":"Halliday","year":"2019","journal-title":"Lancet"},{"key":"2026081102570719700_qcag029-B27","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/ejhf.3732","article-title":"Heart failure improvement, remission, and recovery: a European Journal of Heart Failure expert consensus document","volume":"27","author":"Hulot","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026081102570719700_qcag029-B28","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jchf.2024.03.001","article-title":"Eligibility and projected benefits of rapid initiation of quadruple therapy for newly diagnosed heart failure","volume":"12","author":"Greene","year":"2024","journal-title":"JACC Heart Fail"},{"key":"2026081102570719700_qcag029-B29","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.jacc.2024.11.014","article-title":"Sodium zirconium cyclosilicate for management of hyperkalemia in patients with heart failure with reduced ejection fraction: the REALIZE-K trial","volume":"84","author":"Butler","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026081102570719700_qcag029-B30","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJMoa2201458","article-title":"Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial","volume":"386","author":"Pitt","year":"2022","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B31","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/ejhf.1835","article-title":"Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients","volume":"22","author":"Cautela","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026081102570719700_qcag029-B32","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"2026081102570719700_qcag029-B33","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/ejhf.2920","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: a sub-analysis of the STRONG-HF randomized clinical trial","volume":"25","author":"Arrigo","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026081102570719700_qcag029-B34","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/jcdd10090388","article-title":"Vericiguat: the fifth harmony of heart failure with reduced ejection fraction","volume":"10","author":"Falco","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"2026081102570719700_qcag029-B35","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B36","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B38","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(24)01763-X","article-title":"GLP-1 receptor agonists in heart failure: how far to expand use?","volume":"404","author":"Hage","year":"2024","journal-title":"Lancet"},{"key":"2026081102570719700_qcag029-B39","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cardfail.2023.03.017","article-title":"Increased risk of heart failure hospitalization with GLP-1 receptor agonists in patients with reduced ejection fraction: a meta-analysis of the EXSCEL and FIGHT trials","volume":"29","author":"Neves","year":"2023","journal-title":"J Card Fail"},{"key":"2026081102570719700_qcag029-B40","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/ehjcvp\/pvae026","article-title":"Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries","volume":"10","author":"Wallner","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081102570719700_qcag029-B41","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1001\/jama.2016.10260","article-title":"Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial","volume":"316","author":"Margulies","year":"2016","journal-title":"JAMA"},{"key":"2026081102570719700_qcag029-B42","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1161\/CIRCULATIONAHA.119.041659","article-title":"Effect of once-weekly exenatide in patients with type 2 diabetes mellitus with and without heart failure and heart failure-related outcomes: insights from the EXSCEL trial","volume":"140","author":"Fudim","year":"2019","journal-title":"Circulation"},{"key":"2026081102570719700_qcag029-B43","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B44","author":"Colorado Prevention Center"},{"key":"2026081102570719700_qcag029-B45","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.hrthm.2023.03.1538","article-title":"2023 HRS\/APHRS\/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure","volume":"20","author":"Chung","year":"2023","journal-title":"Heart Rhythm"},{"key":"2026081102570719700_qcag029-B46","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.15420\/aer.2023.03","article-title":"Cardiac resynchronisation with conduction system pacing","volume":"12","author":"Ezzeddine","year":"2023","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"2026081102570719700_qcag029-B47","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.jacep.2025.03.024","article-title":"Clinical response to resynchronization therapy: conduction system pacing vs biventricular pacing: the CONSYST-CRT trial.","volume":"11","author":"Pujol-L\u00f3pez","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"2026081102570719700_qcag029-B48","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1016\/j.jacep.2023.08.003","article-title":"His-purkinje conduction system pacing optimized trial of cardiac resynchronization therapy vs biventricular pacing: HOT-CRT clinical trial","volume":"9","author":"Vijayaraman","year":"2023","journal-title":"J Am Coll Cardiol EP"},{"key":"2026081102570719700_qcag029-B49","author":"UChicago Medicine investigators"},{"key":"2026081102570719700_qcag029-B50"},{"key":"2026081102570719700_qcag029-B51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.hroo.2024.01.004","article-title":"Outcomes with guideline-directed medical therapy and cardiac implantable electronic device therapies for patients with heart failure with reduced ejection fraction","volume":"5","author":"Mignone","year":"2024","journal-title":"Heart Rhythm O2"},{"key":"2026081102570719700_qcag029-B52","author":"PROFID-EHRA investigators"},{"key":"2026081102570719700_qcag029-B53","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026081102570719700_qcag029-B54","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2459\/JCM.0000000000000544","article-title":"Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction","volume":"18","author":"Gronda","year":"2017","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2026081102570719700_qcag029-B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2020.05.015","article-title":"Baroreflex activation therapy in patients with heart failure with reduced ejection fraction","volume":"76","author":"Zile","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026081102570719700_qcag029-B56","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jchf.2015.02.006","article-title":"Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction","volume":"3","author":"Abraham","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026081102570719700_qcag029-B57","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/ejhf.1374","article-title":"Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction","volume":"21","author":"Anker","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026081102570719700_qcag029-B58","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B59","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B60","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B61","author":"Sunnybrook Health Sciences Centre"},{"key":"2026081102570719700_qcag029-B62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5455\/medarh.2022.76.17-22","article-title":"Clinical implications of functional mitral regurgitation severity in patients with heart failure with reduced ejection fraction (HFrEF)","volume":"76","author":"Naser","year":"2022","journal-title":"Med Arch"},{"key":"2026081102570719700_qcag029-B63","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/24748706.2020.1765055","article-title":"Pathoanatomy of mitral regurgitation","volume":"4","author":"Karagodin","year":"2020","journal-title":"Struct Heart"},{"key":"2026081102570719700_qcag029-B64","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B65","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1056\/NEJMoa2314328","article-title":"Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation","volume":"391","author":"Anker","year":"2024","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B66","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2408739","article-title":"Transcatheter repair versus mitral-valve surgery for secondary mitral regurgitation","volume":"391","author":"Baldus","year":"2024","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B67","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B68","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"2026081102570719700_qcag029-B69","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"2026081102570719700_qcag029-B70","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa2304968","article-title":"Ferric carboxymaltose in heart failure with iron deficiency","volume":"389","author":"Mentz","year":"2023","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B71","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B72","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","article-title":"Catheter ablation in end-stage heart failure with atrial fibrillation","volume":"389","author":"Sohns","year":"2023","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B73","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.hrthm.2024.04.098","article-title":"Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction patients: a meta-analysis","volume":"21","author":"Pasqualotto","year":"2024","journal-title":"Heart Rhythm"},{"key":"2026081102570719700_qcag029-B74","author":"William Harvey Research Institute"},{"key":"2026081102570719700_qcag029-B75","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa2405880","article-title":"Transcatheter aortic-valve replacement for asymptomatic severe aortic stenosis","volume":"391","author":"G\u00e9n\u00e9reux","year":"2024","journal-title":"N Engl J Med"},{"key":"2026081102570719700_qcag029-B76","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/j.jacc.2021.04.014","article-title":"Moderate aortic stenosis in patients with heart failure and reduced ejection fraction","volume":"77","author":"Jean","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026081102570719700_qcag029-B77","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jacc.2024.10.070","article-title":"Transcatheter aortic valve replacement in patients with systolic heart failure and moderate aortic stenosis: TAVR UNLOAD","volume":"85","author":"Van Mieghem","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026081102570719700_qcag029-B78","doi-asserted-by":"publisher","first-page":"CD003331","DOI":"10.1002\/14651858.CD003331.pub6","article-title":"Exercise-based cardiac rehabilitation for adults with heart failure","volume":"2024","author":"Molloy","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"2026081102570719700_qcag029-B79","doi-asserted-by":"publisher","first-page":"i1010","DOI":"10.1136\/bmj.i1010","article-title":"Palliative care in patients with heart failure","volume":"353","author":"McIlvennan","year":"2016","journal-title":"BMJ"},{"key":"2026081102570719700_qcag029-B80","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jacc.2017.05.030","article-title":"Palliative care in heart failure: the PAL-HF randomized, controlled clinical trial","volume":"70","author":"Rogers","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026081102570719700_qcag029-B81","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1089\/jpm.2013.0675","article-title":"Engaging heart failure clinicians to increase palliative care referrals: overcoming barriers, improving techniques","volume":"17","author":"Gelfman","year":"2014","journal-title":"J Palliat Med"},{"key":"2026081102570719700_qcag029-B82","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cardfail.2024.10.435","article-title":"Integration of palliative care into heart failure care: consensus-based recommendations from the Heart Failure Society of America","volume":"30","author":"Chuzi","year":"2024","journal-title":"J Card Fail"},{"key":"2026081102570719700_qcag029-B83","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"2026081102570719700_qcag029-B84","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/clc.23970","article-title":"Prevalence of sarcopenia and its association with clinical outcomes in patients with heart failure: a systematic review and meta-analysis","volume":"46","author":"Chen","year":"2023","journal-title":"Clin Cardiol"},{"key":"2026081102570719700_qcag029-B85","doi-asserted-by":"publisher","first-page":"ehad655.991","DOI":"10.1093\/eurheartj\/ehad655.991","article-title":"The effect of long-term application of guideline-directed medical therapy on systolic blood pressure in hospitalized patients with heart failure with reduced ejection fraction","volume":"44","author":"Banfi-Bacsardi","year":"2023","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal - Quality of Care and Clinical Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcag029\/67225430\/qcag029.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/12\/5\/679\/67225430\/qcag029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/12\/5\/679\/67225430\/qcag029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:57:14Z","timestamp":1786431434000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article\/12\/5\/679\/8505611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":85,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,4]]},"published-print":{"date-parts":[[2026,8,11]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjqcco\/qcag029","relation":{},"ISSN":["2058-5225","2058-1742"],"issn-type":[{"value":"2058-5225","type":"print"},{"value":"2058-1742","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,3,4]]}}}